Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221 CHF | +1.01% | -0.50% | -9.61% |
Apr. 26 | Roche: positive CHMP opinion for Alecensa | CF |
Apr. 26 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
195B | ||||||
661B | ||||||
566B | ||||||
352B | ||||||
332B | ||||||
283B |
- Stock Market
- Equities
- ROG Stock
- Charts Roche Holding AG
- Sector Chart